Stimulation of p53 DNA binding by c-Abl requires the p53 c terminus and tetramerization

被引:63
作者
Nie, Y [1 ]
Li, HH [1 ]
Bula, CM [1 ]
Liu, XA [1 ]
机构
[1] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA
关键词
D O I
10.1128/MCB.20.3.741-748.2000
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The carboxyl terminus of p53 is a target of a variety of signals for regulation of p53 DNA binding. Growth suppressor c-Abl interacts with p53 in response to DNA damage and overexpression of c-Abl leads to G(1) growth arrest in a p53-dependent manner. Here, we show that c-Abl binds directly to the carboxyl-terminal regulatory domain of p53 and that this interaction requires tetramerization of p53. Importantly, we demonstrate that c-Abl stimulates the DNA-binding activity of wild-type p53 but not of a carboxyl-terminally truncated p53 (p53363C). A deletion mutant of c-Abl that does not bind to p53 is also incapable of activating p53 DNA binding. These data suggest that the binding to the p53 carboxyl terminus is necessary for c-Abl stimulation. To investigate the mechanism for this activation, we have also shown that c-Abl stabilizes the p53-DNA complex. These results led us to hypothesize that the interaction of c-Abl with the C terminus of p53 may stabilize the p53 tetrameric conformation, resulting in a more stable p53-DNA complex. Interestingly, the stimulation of p53 DNA-binding by c-Abl does not require its tyrosine kinase activity, indicating a kinase-independent function for c-Abl. Together, these results suggest a detailed mechanism by which c-Abl activates p53 DNA-binding via the carboxyl-terminal regulatory domain and tetramerization.
引用
收藏
页码:741 / 748
页数:8
相关论文
共 35 条
[1]   DELETION OF AN N-TERMINAL REGULATORY DOMAIN OF THE C-ABL TYROSINE KINASE ACTIVATES ITS ONCOGENIC POTENTIAL [J].
FRANZ, WM ;
BERGER, P ;
WANG, JYJ .
EMBO JOURNAL, 1989, 8 (01) :137-147
[2]   DIFFERENTIAL RECOGNITION OF TARGET GENES BY NUCLEAR RECEPTOR MONOMERS, DIMERS, AND HETERODIMERS [J].
GLASS, CK .
ENDOCRINE REVIEWS, 1994, 15 (03) :391-407
[3]  
GOGA A, 1995, ONCOGENE, V11, P791
[4]   Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain [J].
Gu, W ;
Roeder, RG .
CELL, 1997, 90 (04) :595-606
[5]   SMALL PEPTIDES ACTIVATE THE LATENT SEQUENCE-SPECIFIC DNA-BINDING FUNCTION OF P53 [J].
HUPP, TR ;
SPARKS, A ;
LANE, DP .
CELL, 1995, 83 (02) :237-245
[6]   REGULATION OF THE SPECIFIC DNA-BINDING FUNCTION OF P53 [J].
HUPP, TR ;
MEEK, DW ;
MIDGLEY, CA ;
LANE, DP .
CELL, 1992, 71 (05) :875-886
[7]   N-TERMINAL MUTATIONS ACTIVATE THE LEUKEMOGENIC POTENTIAL OF THE MYRISTOYLATED FORM OF C-ABL [J].
JACKSON, P ;
BALTIMORE, D .
EMBO JOURNAL, 1989, 8 (02) :449-456
[8]   Identification of redox/repair protein Ref-1 as a potent activator of p53 [J].
Jayaraman, L ;
Murthy, KGK ;
Zhu, C ;
Curran, T ;
Xanthoudakis, S ;
Prives, C .
GENES & DEVELOPMENT, 1997, 11 (05) :558-570
[9]   Proposed mechanism for the stabilization of nuclear receptor DNA binding via protein dimerization [J].
Jiang, GQ ;
Lee, U ;
Sladek, FM .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (11) :6546-6554
[10]   Determination of cell fate by c-Abl activation in the response to DNA damage [J].
Kharbanda, S ;
Yuan, ZM ;
Weichselbaum, R ;
Kufe, D .
ONCOGENE, 1998, 17 (25) :3309-3318